Physiological Characteristics and Temporal Transitions of Preserved Ratio Impaired Spirometry
Background The pattern of preserved ratio impaired spirometry (PRISm) has gained increased attention in the last few years. While PRISm has been linked to increased morbidity and mortality, the underlying physiological causes remain unclear and the stability of PRISm over time remains uncertain. Methods We investigated 6571 individuals (≥25 years, 51.4% female) from the Austrian population-based, longitudinal LEAD study who underwent post-bronchodilator spirometry and body plethysmography twice within a 4-year interval. Individuals were classified into normal spirometry (FEV 1 /FVC≥0.7 and FEV 1 ≥80%predGLI); airflow limitation (AFL; FEV 1 /FVC<0.7); and PRISm (FEV 1 /FVC≥0.7 and FEV 1 <80%predGLI). Body composition was assessed by DXA scanning. Results PRISm was present in 2.6% of individuals (n=171) at baseline. Different subgroups of PRISm were identified: after 4 years, 45.6% had persistent PRISm, 37.4% PRISm-to-normal and 17.0% had PRISm-to-AFL. Persistent PRISm individuals were characterised by significantly lower total lung capacity (TLC), with two thirds meeting TLC criteria for restriction. PRISm-to-AFL had a higher TLC and lower airway conductance as well as a higher FEV 1 decline. Participants with new PRISm after 4 years (n=71) had the highest decline of vital capacity and TLC. Smoking status was not associated with PRISm progression or resolution as never- and ever- smokers with PRISm showed no difference in frequency of transitions after 4 years. Conclusion PRISm is primarily defined by low lung volumes and is characterised by a dynamic course, with more than two thirds demonstrating stable or improving lung function. Lung volume assessment in PRISm is mandatory for precise evaluation of pulmonary function. Similar transition patterns in smokers and never-smokers challenge the assumption of PRISm as an early smoking-related obstructive state and emphasize the importance of repeated lung function testing over time.
Authors
- Robab Breyer‐Kohansal (ORCID: https://orcid.org/0000-0001-5850-5923)
- Frits M.E. Franssen (ORCID: https://orcid.org/0000-0002-1633-6356)
- David A. Kaminsky (ORCID: https://orcid.org/0000-0002-6515-8023)
- Tobias Mraz (ORCID: https://orcid.org/0009-0004-5523-2586)
- Charmaine J. M. Lim (ORCID: https://orcid.org/0009-0007-9398-9629)
- Emiel F.�M. Wouters (ORCID: https://orcid.org/0000-0002-9186-575X)
- Marie-Kathrin Breyer
- Sylvia Hartl (ORCID: https://orcid.org/0000-0002-0734-0070)
- Charles G. Irvin (ORCID: https://orcid.org/0000-0002-5721-2720)
Institutions
- University of Vermont (US)
- Maastricht University (NL)
- Ludwig Boltzmann Institute for Lung Vascular Research (AT)
- Medical University of Vienna (AT)
Publication Details
- Journal
- ERJ Open Research
- Published
- 2025-11-13
- DOI
- https://doi.org/10.1183/23120541.01129-2025
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00